-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on NeuroPace, Raises Price Target to $22

Benzinga·12/16/2025 14:27:34
語音播報
UBS analyst Priya Sachdeva maintains NeuroPace (NASDAQ:NPCE) with a Buy and raises the price target from $18 to $22.